Emissary
Emissary is a New York-based marketing and clinical trial company, founded in 2013. It has raised $21.3M across 3 funding rounds, most recently a $5M Series A in June 2022, from investors including MESA Ventures, Canaan and The Perkins Fund.
Key facts
| Company Operating Status | Active |
|---|---|
| Full Address | 228 Park Ave S, Ste 86223, New York, New York 10003, US |
| Public/Private | Private |
| Wellfound ID | emissary |